Table 3.
Antigen/adjuvant | Vaccine type | Protection % (Reduction in worm burden) | References |
---|---|---|---|
ES/FIA | Crude | 97% | (85) |
EVs and EVs fractions | Crude | Significant reduction (% was not indicated) | (276) |
rPP2A/OVS | r-protein | 97.90% | (277) |
• rTm-WAP49/Montanide ISA 720 • rTm-WAP-F8+Na-GST-1/Montanide ISA 720 |
r-protein | • 48% • 38% |
(91) |
VLPs expressing Trichuris T-cell epitopes | Epitope-based | 50% | (79) |
OVS, Oleic-vinyl sulfone; FIA, Freund's incomplete adjuvant.